Health & Fitness
Tue, March 6, 2012Mon, March 5, 2012Fri, March 2, 2012Thu, March 1, 2012Wed, February 29, 2012Tue, February 28, 2012Mon, February 27, 2012Sat, February 25, 2012Fri, February 24, 2012Thu, February 23, 2012Wed, February 22, 2012Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference
Published in Health and Fitness on Wednesday, February 29th 2012 at 5:13 GMT by Market Wire
Cempra, Inc. to Present at the Cowen and Company 32nd Annual... -- CHAPEL HILL, N.C., Feb. 29, 2012 /PRNewswire/ --
Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference
CHAPEL HILL, N.C., Feb. 29, 2012 /PRNewswire/ -- Cempra, Inc. (NASDAQ: [ CEMP ]) today announced thatPrabhavathi Fernandes, Ph.D., president and chief executive officer, will present at the Cowen and Company 32nd Annual Health Care Conference at 11:20 a.m. EST, March 6, 2012, at The Boston Marriott Copley Place in Boston. Dr. Fernandes will provide an overview of the company's two leading antibiotic clinical programs, solithromycin (CEM-101) for community-acquired bacterial pneumonia and TAKSTA™ for the oral treatment of gram positive pathogens including methicillin-resistant S. aureus (MRSA).
About Cempra, Inc.
Founded in 2006, Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases. Cempra's two lead product candidates have both completed oral Phase 2 clinical trials and seek to address the need for new treatments targeting drug-resistant bacterial infections in the hospital and in the community. The company also intends to utilize its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Additional information about Cempra can be found at [ www.cempra.com ].
Investor Contacts:
Robert E. Flamm, Ph.D.
Russo Partners, LLC
(212) 845-4226
[ Robert.flamm@russopartnersllc.com ]
Andreas Marathovouniotis
Russo Partners, LLC
(212) 845-4235
[ Andreas.marathis@russopartnersllc.com ]
Media Contact:
Elliot Fox
Russo Partners, LLC
(212) 845-4253
[ Elliot.fox@russopartnersllc.com ]
SOURCE Cempra, Inc.
[ Back to top ] RELATED LINKS
[ http://www.cempra.com ]
